- Home
- NRSN vs DFLI Comparison
NRSN vs DFLI Comparison
Compare NRSN & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | DFLI |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | Israel | United States |
| Employees | 16 | 141 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 25.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | DFLI |
|---|---|---|
| Price | $0.69 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.50 | $3.25 |
| AVG Volume (30 Days) | 215.7K | ★ 376.4K |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $583.67 | $51.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.15 |
| 52 Week High | $2.18 | $5.15 |
Technical Indicators
Market Signals| Indicator | NRSN | DFLI |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 45.77 |
| Support Level | $0.68 | $1.67 |
| Resistance Level | $0.75 | $2.26 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 8.47 | 23.86 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is engaged in the design, assembly, and sale of lithium-ion batteries, mainly lithium iron phosphate (LFP) batteries, for applications in recreational vehicles, marine, industrial, and other markets. The company operates through two segments: direct-to-consumer (DTC), which sells Battle Born branded batteries, and OEM, which supplies Dragonfly branded batteries to original equipment manufacturers.